GlaxoSmithKline | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Alcon AG USD 468M 73M 2025-03
Almirall EUR 3.38M 49.66M 2024-12
Amgen USD 1.29B 1.02B 2025-03
argenx SE USD 138.94M 35.9M 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Fresenius EUR 687M 218M 2025-03
Fresenius Medical Care EUR 331M 72.1M 2025-03
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 188M 2B 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
GRIFOLS EUR 268.86M 103M 2025-03
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Orion EUR 77.9M 14.8M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Philips EUR 154M 45M 2025-03
Recordati EUR 195.77M 33.09M 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Smith & Nephew USD 329M 1000K 2024-12
UCB EUR 163M 39M 2024-06



GlaxoSmithKline L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.